Abstract
Patients with gastrointestinal (GI) cancer are exposed to cachexia, which is highly correlated with chemotherapy-induced side effects. Research suggests that specific immunonutrients could prevent such toxicities. The primary objective of this phase III study was to evaluate the efficacy of glutamine and transforming growth factor-β2 (TGF-β2) in the prevention of grade 3-4 non-hematological toxicities induced by chemotherapy in patients with GI cancer. We designed a double-blind, randomized, controlled and multicenter trial stratified according to center, type of chemotherapy, presence of cachexia, and age. Patients were randomized to receive either Clinutren Protect(®) (CP) or a control isocaloric diet (without TGF-β2 or glutamine). Between November 2007 and October 2011, 210 patients were enrolled in the study, of which 201 were included in the intention-to-treat analysis. Grade 3-4 non-hematological toxicities were not significantly different between the CP and control groups when evaluated by univariate and multivariate analyses. Likewise, no difference was observed regarding grade 3-4 hematological toxicities or reasons for treatment interruption. This randomized study does not support the hypothesis that oral glutamine an...Continue Reading
References
Jul 1, 1997·Nutrition·F BozzettiE Baietta
Aug 26, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H J AndreyevD Cunningham
Jun 11, 1999·American Journal of Clinical Oncology·S H OkunoN Pierson
Jan 29, 2000·Immunology and Cell Biology·A Donnet-HughesE J Schiffrin
Mar 29, 2000·Alimentary Pharmacology & Therapeutics·J M FellJ A Walker-Smith
Dec 15, 2000·Gut·B DanieleL D'Agostino
Oct 31, 2003·Cancer Treatment Reviews·Diane M F SavareseBarbara Corey
Feb 3, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paula RavascoMaria Ermelinda Camilo
Mar 15, 2005·Nutrition Reviews·Moïse Coëffier, Pierre Déchelotte
May 28, 2005·Head & Neck·Paula RavascoMaria Ermelinda Camilo
Sep 6, 2005·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Judith BauerUNKNOWN Cancer Cachexia Study Group
May 16, 2006·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·H LochsC Pichard
May 16, 2006·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·J ArendsUNKNOWN ESPEN (European Society for Parenteral and Enteral Nutrition)
Jul 25, 2006·Journal of Dental Research·M A StokmanE G E de Vries
Nov 2, 2006·Digestive Diseases and Sciences·Bernd SidoWulf Dröge
Dec 13, 2006·Cancer·Douglas E PetersonRobert G Petit
Apr 5, 2007·The Oncologist·Wei-Shu WangPo-Min Chen
Apr 2, 2008·The Oncologist·Florian StrasserSilke Gillessen
Nov 22, 2008·The Journal of Nutrition·Stéphane LecleireMoïse Coëffier
Aug 29, 2009·JPEN. Journal of Parenteral and Enteral Nutrition·David Allen AugustUNKNOWN American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors
Nov 17, 2009·Digestive Diseases and Sciences·Nabile BoukhettalaMoïse Coëffier
Feb 26, 2010·The Journal of Nutrition·Nabile BoukhettalaMoïse Coëffier
Feb 8, 2011·The Lancet Oncology·Kenneth FearonVickie E Baracos
May 6, 2014·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·UNKNOWN French Speaking Society of Clinical Nutrition and Metabolism (SFNEP)
Jul 3, 2015·Journal of Cachexia, Sarcopenia and Muscle·Joyce FaberAte van der Gaast